Organization
Trillium Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Trillium Therapeutics, Inc.
... TORONTO - Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
... TORONTO - Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
... 2018 14:18 EDT ORIGINAL ANNOUNCEMENT [Text] TORONTO, Sept. 28, 2018 -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
... CANADIAN DAILY STOCK REPORT Trillium Therapeutics Inc. (TSX:TRIL), Canada's 14th largest Biotechnology company by market cap, extended its ...
... 2018 14:30 EDT ORIGINAL ANNOUNCEMENT [Text] TORONTO, Sept. 27, 2018 -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
... CANADIAN WEEKLY STOCK REPORT Trillium Therapeutics Inc. (TSX:TRIL), Canada's 17th largest Biotechnology company by market cap, has dropped ...
... CANADIAN WEEKLY STOCK REPORT Trillium Therapeutics Inc. (TSX:TRIL), Canada's 17th largest Biotechnology company by market cap, has climbed ...
... CANADIAN WEEKLY STOCK REPORT Trillium Therapeutics Inc. (TSX:TRIL), Canada's 16th largest Biotechnology company by market cap, has decreased ...
... CANADIAN WEEKLY STOCK REPORT Trillium Therapeutics Inc. (TSX:TRIL), Canada's 16th largest Biotechnology company by market cap, has climbed ...
... 2018 17:39 EDT ORIGINAL ANNOUNCEMENT [Text] TORONTO, Aug. 30, 2018 -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
Subscribe now for full coverage on Trillium Therapeutics, Inc.
Start My Free Trial